January 5, 2023
This trial is evaluating the effect of adding immune system therapy to the usual treatment (chemotherapy and radiation)
January 5, 2023
This trial is seeking to find out whether patients with the PD-L1 biomarker can either delay having chemotherapy or avoid it altogether
January 5, 2023
Adding immunotherapy to standard chemotherapy keeps most patients in remission and improves their survival
September 26, 2022
Researchers at ECOG-ACRIN are studying if they can improve results for patients with liver cancer by giving chemotherapy along with drugs that help the body’s immune system fight cancer